Added to YB: 2025-11-13
Pitch date: 2025-11-10
BTMD [neutral]
biote Corp.
+4.8%
current return
Author Info
Contrarian Cashflows publishes a monthly deep dive on a new value stock. Sign up for the newsletter.
Company Info
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance.
Market Cap
$81.3M
Pitch Price
$2.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
4.20
P/E
3.23
EV/Sales
0.85
Sector
Pharmaceuticals
Category
value
Monday Delight: 10/11/25 - biote Corp.
BTMD (quick overview): Hormone optimization 'franchise' model certifying practitioners, providing training/software/marketing support + branded HRT products. Capital-light with strong buybacks, activist engagement. 3.1x P/E, 4.3x EV/EBIT. Risk: controversial bioidentical pellet therapy efficacy vs traditional HRT.
Read full article (1 min)